Intuitive Surgical, Inc. (0R29.L)
USD 432.41
(-5.81%)
USD 432.41
(-5.81%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.04 Billion USD | 9.82% |
| 2022 | 1.86 Billion USD | 16.08% |
| 2021 | 1.6 Billion USD | 13.74% |
| 2020 | 1.4 Billion USD | -2.67% |
| 2019 | 1.44 Billion USD | 24.96% |
| 2018 | 1.15 Billion USD | 12.41% |
| 2017 | 1.03 Billion USD | 45.42% |
| 2016 | 709.1 Million USD | 20.64% |
| 2015 | 587.8 Million USD | 1.34% |
| 2014 | 580 Million USD | 29.2% |
| 2013 | 448.9 Million USD | -6.3% |
| 2012 | 479.1 Million USD | 14.75% |
| 2011 | 417.5 Million USD | 18.27% |
| 2010 | 353 Million USD | 29.57% |
| 2009 | 272.43 Million USD | 31.07% |
| 2008 | 207.85 Million USD | 37.36% |
| 2007 | 151.32 Million USD | 84.35% |
| 2006 | 82.08 Million USD | 39.14% |
| 2005 | 58.99 Million USD | 50.13% |
| 2004 | 39.29 Million USD | 9.05% |
| 2003 | 36.03 Million USD | 29.16% |
| 2002 | 27.9 Million USD | 26.43% |
| 2001 | 22.06 Million USD | 1.74% |
| 2000 | 21.69 Million USD | 77.16% |
| 1999 | 12.24 Million USD | 402.21% |
| 1998 | 2.43 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.78 Billion USD | -12.85% |
| 2024 Q2 | 1.85 Billion USD | 4.03% |
| 2024 Q3 | 2.06 Billion USD | 11.47% |
| 2023 Q3 | 2.08 Billion USD | 7.49% |
| 2023 FY | 2.04 Billion USD | 9.82% |
| 2023 Q1 | 1.75 Billion USD | -5.5% |
| 2023 Q2 | 1.94 Billion USD | 10.49% |
| 2023 Q4 | 2.04 Billion USD | -2.15% |
| 2022 Q3 | 1.68 Billion USD | 3.94% |
| 2022 Q2 | 1.62 Billion USD | 6.66% |
| 2022 Q1 | 1.52 Billion USD | -5.11% |
| 2022 FY | 1.86 Billion USD | 16.08% |
| 2022 Q4 | 1.86 Billion USD | 10.35% |
| 2021 Q2 | 1.41 Billion USD | 4.98% |
| 2021 Q3 | 1.47 Billion USD | 4.06% |
| 2021 Q4 | 1.6 Billion USD | 8.7% |
| 2021 FY | 1.6 Billion USD | 13.74% |
| 2021 Q1 | 1.35 Billion USD | -4.23% |
| 2020 Q3 | 1.33 Billion USD | -0.48% |
| 2020 Q1 | 1.36 Billion USD | -6.07% |
| 2020 FY | 1.4 Billion USD | -2.67% |
| 2020 Q2 | 1.33 Billion USD | -1.72% |
| 2020 Q4 | 1.4 Billion USD | 5.94% |
| 2019 Q4 | 1.44 Billion USD | 6.96% |
| 2019 Q2 | 1.25 Billion USD | 4.81% |
| 2019 Q3 | 1.35 Billion USD | 8.16% |
| 2019 Q1 | 1.19 Billion USD | 3.05% |
| 2019 FY | 1.44 Billion USD | 24.96% |
| 2018 Q1 | 919.8 Million USD | -10.8% |
| 2018 FY | 1.15 Billion USD | 12.41% |
| 2018 Q4 | 1.15 Billion USD | 12.53% |
| 2018 Q3 | 1.03 Billion USD | 5.07% |
| 2018 Q2 | 980.4 Million USD | 6.59% |
| 2017 FY | 1.03 Billion USD | 45.42% |
| 2017 Q3 | 684.7 Million USD | -6.01% |
| 2017 Q2 | 728.5 Million USD | 7.05% |
| 2017 Q1 | 680.5 Million USD | -4.03% |
| 2017 Q4 | 1.03 Billion USD | 50.61% |
| 2016 Q3 | 632.9 Million USD | 5.61% |
| 2016 FY | 709.1 Million USD | 20.64% |
| 2016 Q1 | 555.9 Million USD | -5.43% |
| 2016 Q4 | 709.1 Million USD | 12.04% |
| 2016 Q2 | 599.3 Million USD | 7.81% |
| 2015 Q3 | 567.1 Million USD | 0.94% |
| 2015 Q1 | 540.8 Million USD | -6.76% |
| 2015 Q2 | 561.8 Million USD | 3.88% |
| 2015 Q4 | 587.8 Million USD | 3.65% |
| 2015 FY | 587.8 Million USD | 1.34% |
| 2014 Q2 | 582.2 Million USD | 8.3% |
| 2014 Q1 | 537.6 Million USD | 19.76% |
| 2014 Q3 | 567.3 Million USD | -2.56% |
| 2014 Q4 | 580 Million USD | 2.24% |
| 2014 FY | 580 Million USD | 29.2% |
| 2013 Q1 | 463.6 Million USD | -3.24% |
| 2013 Q4 | 448.9 Million USD | 3.65% |
| 2013 FY | 448.9 Million USD | -6.3% |
| 2013 Q2 | 482.5 Million USD | 4.08% |
| 2013 Q3 | 433.1 Million USD | -10.24% |
| 2012 FY | 479.1 Million USD | 14.75% |
| 2012 Q3 | 438.7 Million USD | -1.13% |
| 2012 Q4 | 479.1 Million USD | 9.21% |
| 2012 Q1 | 405.6 Million USD | -2.85% |
| 2012 Q2 | 443.7 Million USD | 9.39% |
| 2011 FY | 417.5 Million USD | 18.27% |
| 2011 Q3 | 377 Million USD | 4.32% |
| 2011 Q2 | 361.4 Million USD | 7.11% |
| 2011 Q1 | 337.4 Million USD | -4.42% |
| 2011 Q4 | 417.5 Million USD | 10.74% |
| 2010 Q3 | 343.5 Million USD | 7.78% |
| 2010 Q2 | 318.7 Million USD | 29.24% |
| 2010 Q4 | 353 Million USD | 2.77% |
| 2010 Q1 | 246.6 Million USD | -9.48% |
| 2010 FY | 353 Million USD | 29.57% |
| 2009 FY | 272.43 Million USD | 31.07% |
| 2009 Q2 | 230.09 Million USD | 9.09% |
| 2009 Q3 | 247.54 Million USD | 7.58% |
| 2009 Q4 | 272.43 Million USD | 10.05% |
| 2009 Q1 | 210.93 Million USD | 1.48% |
| 2008 Q3 | 181.24 Million USD | 15.15% |
| 2008 Q1 | 141.47 Million USD | -6.51% |
| 2008 Q2 | 157.4 Million USD | 11.26% |
| 2008 Q4 | 207.85 Million USD | 14.68% |
| 2008 FY | 207.85 Million USD | 37.36% |
| 2007 Q3 | 112.09 Million USD | 15.15% |
| 2007 Q2 | 97.34 Million USD | 20.28% |
| 2007 Q1 | 80.93 Million USD | -1.4% |
| 2007 Q4 | 151.32 Million USD | 35.0% |
| 2007 FY | 151.32 Million USD | 84.35% |
| 2006 Q1 | 55.81 Million USD | -5.4% |
| 2006 FY | 82.08 Million USD | 39.14% |
| 2006 Q4 | 82.08 Million USD | 16.69% |
| 2006 Q3 | 70.34 Million USD | 12.07% |
| 2006 Q2 | 62.76 Million USD | 12.46% |
| 2005 FY | 58.99 Million USD | 50.13% |
| 2005 Q4 | 58.99 Million USD | 24.74% |
| 2005 Q3 | 47.29 Million USD | 13.94% |
| 2005 Q2 | 41.51 Million USD | 6.43% |
| 2005 Q1 | 39 Million USD | -0.75% |
| 2004 Q2 | 33.53 Million USD | 4.19% |
| 2004 Q3 | 37.04 Million USD | 10.49% |
| 2004 Q1 | 32.18 Million USD | -10.69% |
| 2004 Q4 | 39.29 Million USD | 6.07% |
| 2004 FY | 39.29 Million USD | 9.05% |
| 2003 FY | 36.03 Million USD | 29.16% |
| 2003 Q4 | 36.03 Million USD | 5.63% |
| 2003 Q3 | 34.11 Million USD | -16.6% |
| 2003 Q2 | 40.9 Million USD | 51.19% |
| 2003 Q1 | 27.05 Million USD | -3.02% |
| 2002 FY | 27.9 Million USD | 26.43% |
| 2002 Q3 | 26.98 Million USD | 17.29% |
| 2002 Q2 | 23 Million USD | 4.32% |
| 2002 Q1 | 22.05 Million USD | -0.06% |
| 2002 Q4 | 27.9 Million USD | 3.39% |
| 2001 Q2 | 17.31 Million USD | 7.43% |
| 2001 Q1 | 16.11 Million USD | -25.69% |
| 2001 FY | 22.06 Million USD | 1.74% |
| 2001 Q3 | 18 Million USD | 3.98% |
| 2001 Q4 | 22.06 Million USD | 22.56% |
| 2000 Q1 | 12.74 Million USD | 0.0% |
| 2000 FY | 21.69 Million USD | 77.16% |
| 2000 Q3 | 16.59 Million USD | 8.54% |
| 2000 Q2 | 15.28 Million USD | 19.94% |
| 2000 Q4 | 21.69 Million USD | 30.72% |
| 1999 FY | 12.24 Million USD | 402.21% |
| 1998 FY | 2.43 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -1608.683% |
| Accuray Incorporated | 423.54 Million USD | -382.643% |
| Align Technology, Inc. | 2.45 Billion USD | 16.678% |
| Elevance Health Inc. | 69.52 Billion USD | 97.06% |
| AxoGen, Inc. | 101.16 Million USD | -1920.719% |
| Boston Scientific Corporation | 15.6 Billion USD | 86.901% |
| CVS Health Corporation | 173.09 Billion USD | 98.819% |
| Cardinal Health, Inc. | 48.33 Billion USD | 95.771% |
| Centene Corporation | 58.68 Billion USD | 96.517% |
| DaVita Inc. | 14.87 Billion USD | 86.259% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 96.293% |
| Hologic, Inc. | 4.02 Billion USD | 49.225% |
| Humana Inc. | 30.74 Billion USD | 93.352% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -15.141% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 76.861% |
| Masimo Corporation | 1.67 Billion USD | -21.918% |
| McKesson Corporation | 69.04 Billion USD | 97.039% |
| Patterson Companies, Inc. | 1.89 Billion USD | -7.873% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 73.117% |
| ResMed Inc. | 2 Billion USD | -1.785% |
| Henry Schein, Inc. | 5.42 Billion USD | 62.284% |
| Teladoc Health, Inc. | 2.06 Billion USD | 1.069% |
| Universal Health Services, Inc. | 8.15 Billion USD | 74.933% |
| Veeva Systems Inc. | 1.26 Billion USD | -61.457% |
| Baxter International Inc. | 19.8 Billion USD | 89.68% |
| Becton, Dickinson and Company | 26.98 Billion USD | 92.424% |
| Danaher Corporation | 30.99 Billion USD | 93.405% |
| Stryker Corporation | 21.31 Billion USD | 90.411% |
| Medtronic plc | 39.56 Billion USD | 94.833% |